INTRODUCTION: In this research, it was aimed to evaluate effects of botulinum toxin (BoNT) and factors on weight loss in patients with gastric balloon (GB) and without GB.
METHODS: A total of 629 patient files attempted to our clinic between December 2020 to December 2022 were subjected to the study divided by two groups as patients with (GB, n=512) and without GB (NGB, n=117).
RESULTS: Male rate in GB group was significantly higher (p<0.05). Body mass index (BMI), weight, weight difference and BMI difference means were significantly higher in GB group (p<0.05). Ursactive rate was significantly higher in NGB group (p<0.05). Age, height, last weight, hormone usage, hunger, medicine, illness, and diet history differences were insignificant (p>0.05). Weight difference was significantly correlated with group (r=−0.212; p<0.01), gender (r=0.161; p<0.01), BMI (r=0.305; p<0.01), BMR (r=0.268; p<0.01), height (r=0.151; p<0.01), weight (r=0.333; p<0.01), and medicine usage (r=−0.072; 0.05). BMI difference was significantly correlated with group (r=−0.209; p<0.01), BMI (r=0.308; p<0.01), BMR (r=0.165; p<0.01), and weight (r=0.250; p<0.01). GB (B=2.410; p<0.01), BMI (B=0.344; p<0.01), and BMR (B=0.004; p<0.01) had significant contribution on weight difference.
DISCUSSION AND CONCLUSION: BoNT is more effective in patients with GB than patients without GB.